Back to funds

Enavate Sciences GP, LLC

Updated 6 days ago

Managed by Enavate Sciences Gp, Llc • Latest filing Q3 2026

Portfolio value
$279.8M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$506.8M
Q1 2026$351.5M
Q2 2026$345.4M
Q3 2026$279.8M

Top holdings

8 positions as of Q3 2026

View filing
Z

ZENAS BIOPHARMA INC

Value
$78.7M
Shares
2.92M
% Port
28.14%
I

IMMUNOME INC

Value
$77.7M
Shares
3.61M
% Port
27.79%
?
3.N/A

BRAVEHEART BIO INC

Value
$74.2M
Shares
3.67M
% Port
26.53%
S

SIONNA THERAPEUTICS INC

Value
$13M
Shares
2.48M
% Port
4.66%
?
5.N/A

UPSTREAM BIO INC

Value
$13M
Shares
2.46M
% Port
4.63%
?
6.N/A

BRIDGEBIO ONCOLOGY THERAPEUT

Value
$10.8M
Shares
2.63M
% Port
3.85%
?
7.N/A

COMPASS THERAPEUTICS INC

Value
$8.1M
Shares
7.79M
% Port
2.90%
C

CAMP4 THERAPEUTICS CORP

Value
$4.2M
Shares
1.04M
% Port
1.50%

Explore